Abstunct. Rice culture of Aspergillus ochraceus that contained ochratoxin A or pure crystalline ochratoxin A was administered orally daily to 23 young male Beagle dogs. Six other young male Beagles served as controls. Most dogs were killed in extuenzis on or before day 14 after receiving a daily oral dose of ochratoxin A, 0.2-3.0 nig/kg body weight. Consistent clinical features of the mycotoxicosis were anorexia, weight loss, emesis, tenesmus, passage of clots of blood-stained mucus from the rectum, rectal temperature up to 107 "F, tonsillitis, dehydration and prostration. The prominent clinicopathological features of the toxicosis were a reflection of renal damage. The urine had a specific gravity as low as 1.004 and contained granular casts, necrotic renal epithelium, and concentrations above normal of protein, glucose, lactic dehydrogenase, isocitric dehydrogenase, leucine aminopeptidase, glutamic-pyruvic transaminase, glutamic-oxalacetic transaminase, and alkaline phosphatase. Serum concentrations of these enzymes did not change. Concentrations of blood urea nitrogen remained, with two exceptions, within the normal range, but theconcentrations of blood glucose declined terminally. Serum concentrations of the liver-specific enzyme, y-glutamyl transpeptidase and sulfabromophthalein dye retention time did not indicate hepatic dysfunction.
Mycotoxic diseases of the dog have been studied little, and descriptions of natural and experimental mycotoxicosis are limited to aflatoxicosis. Aflatoxins are toxic metabolites produced by fungi of the Aspergillus flawsparasiticus group, many of which are common storage fungi [2,24,26,3 1,651 . Aflatoxins were responsible in England in 1960 for severe losses in poultry fed contaminated peanut meal [ 1, 131, and they also have been implicated in losses of pigs [33] and calves [34] .
Prior to discovery of the aflatoxins, a specific disease in dogs and swine was recognized in the southeastern United States, and this was later established as mycotoxic. In 1952, SIEBOLD and BAILEY [59] described an epizootic of hepatitis in dogs from the southeastern states. This distinctive disease, later called hepatitis X [58] , was reproduced by feeding a commercial dog food containing peanut meal [40] and moldy corn obtained from farms where swine were affected with moldy corn poisoning [4, 671. Clinically, affected dogs had anorexia, depression, and icterus. Necropsy findings included jaundice, discolored livers and hemorrhages in several tissues. Severe hepatic damage was the salient histopathological alteration. In 1957, moldy corn poisoning was described in swine and reproduced by feeding of cultures of A. j'avus and Penicillium rubrum [9] . Many of the pathological features of moldy corn poisoning of swine were similar to those of hepatitis X of dogs. WILSON et al. [67] described the toxicosis produced in swine by administration of crystalline aflatoxins. Their data and the findings of others [4, 611 strongly suggest that the outbreak of moldy corn poisoning was an epizootic of aflatoxicosis. The acute toxicity of aflatoxin B, to the dog was studied by NEWBERNE et al. [41] and by CHAFFEE et al. [14] . Clinical and pathological features of experimental aflatoxicosis resembled field cases of hepatitis X.
These data indicate that the dog is sensitive to the aflatoxins. Because cereals used in dog food could be contaminated with mycotoxins, it is important that the response of dogs to known mycotoxins be determined. A recently described mycotoxin is ochratoxin A, first isolated in 1965 from cultures of A. ochraceus [63] and later identified as a metabolite of Penicillium viridicatum [64] and other members of the A . ochraceus group [25, 321 . This mycotoxin has been found as a natural contaminant of corn [56, 571 and Canadian wheat [54] . Ochratoxin A has been established as nephrotoxic in the rat [38, 45] , and the feeding of ochratoxin-producing cultures of A . ochraceus or ochratoxin A to chicks resulted in renal and hepatic damage with depletion of lymphoid tissue in the bursa of Fabricius [16, 20, 431. Ochratoxicosis was produced in young Beagle dogs, and the clinical and clinicopathological features of the induced toxicosis are the basis of this paper.
Materials and Methods
Twenty-three, 8-to 9-week-old male Beagle dogs were housed in pens and metabolism cages in a building with environmental controls. Fresh drinking water was available ad libitum, and a canned commercial dog food was offered for a 30-min period morning and afternoon. Daily changes in body weight, feed consumption, rectal temperature, water consumption, urinary output and general condition were obtained during a 2-to 3-week acclimation period. This study consists of eight trials in which either rice culture containing ochratoxin A or pure ochratoxin A was orally administered (table I) A fungal rice culture of A . ucIiroceiu was prepared according to methods described by CARLTON and TUITE [12] . The ground rice culture contained 1,600 ppni of ochratoxin A by spectrophotofluorometric analysis.'
Crystalline purified ochratoxin A, purchased from a commercial source*, and the rice culture were weighed and placed in hard gelatin capsules for administration. In trials I to V the rice culture containing ochratoxin A was used, and in trials V1 to VIIl the toxicosis was reproduced by administration of ochratoxin A.
The dogs were bled from a jugular vein every second day from the initiation of dosing to termination at days 1 1-14. Blood for hematological determinations was collected into tubes containing an anticoagulant. The serum for chemical determinations was harvested Analysis by R. CALDWELL, Dept. of Plant Pathology, Purdue University, Lafayette, Ind. Makor Chemicals Ltd., Jerusalem, Israel. from other samples allowed to clot. Hemoglobin concentrations were determined by a cyanniethemoglobin method using a photoelectric reading Total leukocyte (WBC) counts were done with an electronic counting d e~i c e ,~ and the packed cell volume (PCV) was determined by a standard microhematocrit method. Total plasma protein concentrations were estimated with a refractometer as described by BARRY et al. [S] .
Concentrations of the enzyme alkaline phosphatase were determined in serum in trials 111 to VIII and in urine in trials VII and VIII, according to the method of BABSON et al. [3] . Lacticdehydrogenase (LDH) concentrations in serum in trials V to VII and urine in trial VII were determined according to the method of BERGER and BROIDA [7] . A colorimetric method 1601 was used to determine concentrations of isocitric dehydrogenase (ICDH) in serum (trials V to VII) and urine (trial VII). Serum was also tested for concentrations of glutamicpyruvic transaminase (GPT) in trials 111 to VII by the method of REITMAN and FRANKEL [48] . In trial VIII, concentrations of GPT and the enzymes glutamic-oxalacetic transaminase (GOT) and leucine amino peptidase (LAP) were determined in serum and urine by use of a commercially available enzyme test system.5 Serum concentrations of y-glutamyl transpeptidase (GGTP) were determined according to the method of SZASZ [62] in trial VII.
In trial VII concentrations of sodium and potassium were determined in the serum by flame photometry, and serum concentrations of chloride were determined according to the method of COTLOVE et 01. [17] . Blood urea nitrogen concentrations were routinely determined in trials I l l to VIII with urea nitrogen chromatography paper,6 and the results of these determinations were monitored with the Hycel chemical procedure. The Hycel colorimetric method was used to determine concentrations of blood glucose in trials IV to VII.
Six dogs (trials VII and VIII) were kept in metabolism cages to determine the daily water intake and urinary output. In trials 111 to VII urine was collected into chilled flasks. A routine urinalysis was completed twice in the pretrial period and every second day during the test. The tests included the determination of specific gravity and p H as well as use of diagnostic reagent stripsa for the detection of protein, glucose, ketone bodies, urobilinogen, blood and bile. The urinary sediment after centrifugation was lightly stained" for microscopic examination. Unstained sediment was examined with dark-field illumination and by phase contrast microscopy [52] . Urine that was dialyzed for 2 h against running water was used for enzyme determinations.
In trial VIII, twice during the pretrial period and on test days 1 and 2, 20 ml of urine from each dog were concentrated to 1 ml by evaporation through dialysis tubing for cellulose acetate membrane electrophoresis [SS]. In trials V to VII BSP dye hepatic function tests based on the method of ROsENTHAL and WHITE [50] were performed twice on each dog in the control period and on test days 5, 8, and 12.
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The rice culture, aseptically collected blood and urine from the dogs of trial V and the medial retropharyngeal lymph nodes and livers from four other dogs (trials IV and VI) were inoculated onto blood agar and McConkey agar plates. The plates were incubated at 37 "C and were examined for bacterial growth at 24 and 48 h.
Except for the dogs that died in trials I and 11, dogs were killed when moribund by the intravenous administration of barbiturates and exsanguination. Mean values for the several clinical and clinicopathological determinations in each trial were calculated and compared with control values that included a range off 1 SD.
Results

Clinical Signs
Clinical features of the mycotoxicosis were anorexia, emesis, tenesmus, retching, elevated rectal temperatures (in some dogs to a high of 107 O F ) , passage of clots of blood-stained mucus from the rectum, polydipsia, polyuria, dehydration, prostration, and death. In trials I and I1 anorexia was complete after the first dose of rice culture, but in trials I11 to VII the lower doses of the culture caused a more gradual decline in feed consumption over a 6to 7-day period as typified by the dogs of trials VI and VII ( fig. 1 ). In trial I dosing was suspended when peracute mycotoxic disease occurred on day 1 after the dogs received ochratoxin A, 7-9 mg/kg body weight. The dogs survived for 3 more days. In trial I1 the dogs died on day 2 after receiving two doses of rice culture (2.7-3 mg/kg body weight per dose). When the dose was further decreased (0.1-0.3 mg/kg body weight) in trials 111 to V the dogs developed a more gradual toxicosis over a 10-to 14-day period. This was characterized by progressive loss of body weight and increases in rectal temperature, which occurred concurrently with anorexia ( fig. 1 ). In trials I and I1 the larger doses of rice culture induced gastrointestinal disturbances characterized by diarrhea, emesis, tenesmus and retching. These clinical signs also occurred at the lower doses (trials 111 to V) and by day 4 were pronounced in all dogs. In trials 111 to V, emesis occurred within 15-30 min after the feeding period regularly on days 1 and 2 of dosing. During the first 2 days, diarrhea occurred, but by days 3 to 4 when food intake was decreasing the prominent clinical signs were retching, severe tenesmus and the passage of blood and bile-stained clots of mucus from the rectum. The highest rectal temperature of 107 O F occurred on day 8 in one dog in trial V, but most rectal temperatures were in the range of 104-105 O F and were recorded on days 3 to 4. An increase in rectal temperature of at least 2-3 O F was a consistent feature and occurred as early as days 2 or 3 in some dogs and as late as days 9 t o 10 in others. The individual variation in temperature response is reflected in the mean values shown in figure 1. Tonsillitis and conjunctivitis were prominent by day 4 in the dogs in trials 111 t o V. Bilateral mucopurulent exudate, which accumulated at the medial canthus, was attributed t o necrosis of lymphoid tissue on the interior aspect of the nictitating membrane. The tonsils were hyperemic in all these dogs and by day 4 were markedly enlarged and protruded from the crypts. The tonsillitis and the conjunctivitis persisted to death in all dogs.
Additional features of the mycotoxicosis were polydipsia, polyuria, and dehydration in the dogs of trials I11 to V. Polydipsia and polyuria were quantitated in trial VII (fig. 2) . The tendency of the dogs to consume more water was apparent in this trial by day 2, and increased urinary output followed on day 3. By day 3, two of the three dogs were in negative water balance as they voided during a 24-hour period a larger volume of urine than the volume of water consumed. The polydipsia and polyuria were progressive, and by day 11 one dog drank as much as 850 ml of water in a 24-hour period and voided 820 ml of urine. Water consumption and urine output (at day 11) of the other two dogs in this trial were between 200 and 300 m1/24 h, which was in the upper range of control values.
In trials VI and VII, in which daily doses of 0.2-0.4 mg/kg body weight of pure crystalline ochratoxin A were given, clinical signs were as outlined for dogs given comparable doses of toxin in the form of rice culture. When a higher dose of 3.0 mg/kg body weight of the pure toxin was used in trial VIII all dogs were dead by day 3. Emesis, diarrhea, tenesmus, complete anorexia, rectal temperatures as high as 106 O F by day 2, and prostration characterized the clinical features in these dogs. These features closely paralleled those of the mycotoxicosis induced by comparable high doses of ochratoxin A given as rice culture in trials I and 11.
Clinicopathological Determinations
Enzymes in Serum There were no consistent ochratoxin-induced changes in serum concentrations of the several enzymes studied. In trials 111 to VIII serum GPT and alkaline phosphatase remained within normal limits and were comparable to control values ( fig. 3 ). Serum alkaline phosphatase varied greatly in control as well as in treated dogs. Serum concentrations of ICDH in the eight test fig. 4 ). There was no change in serum concentrations of GGTP in trial VII. In trial VIII serum GOT rose from pretrial values of 5 mU/ml to 61 mU/ml on day 2 when the dogs were moribund (table 11) .
Enzymes in Urine
The gradually increasing activity of ICDH and LDH in the urine of test dogs in trial VII ( fig. 5 ) was apparent until days 6 to 8 and was in contrast to the lack of such elevation in the serum. In trial VII concentrations of alkaline phosphatase in the urine of test dogs were within the range of control values except for the pretrial period during which a mean concentration of 100 Bodansky units/ml of urine was once recorded ( fig. 5 ). In trial VIII GOT, GPT, LAP and alkaline phosphatase in the urine of the test dogs were markedly elevated by day 2 when the dogs were moribund (table TI) . Also, in this trial G O T in the urine increased from pretrial levels of 7-8 mIU/ml to 17 on day 1 and 236 on day 2. As noted earlier there was a corresponding but much less pronounced elevation of this enzyme in the serum. Glutamic-pyruvic trans- aminase in the urine rose from pretrial values of 9-10 mIU/ml t o values of 20 on day 1 and 42 on day 2, but serum concentrations were not increased. Leucine amino peptidase in the urine was elevated from a pretrial average value of 7 mIU/ml t o 14 on day 1 and t o 70 on day 2. There was no corresponding elevation in serum concentrations of this enzyme.
In trial VIII there was no change in serum alkaline phosphatase but in the urine it was markedly elevated by day 2. Dilutions and adjustments to incubation time were necessary to allow readings of up to 507 Bodansky units/ml of urine.
Urina fysis
Proteinuria, glucosuria, turbidity, and the presence of numerous granular casts and necrotic renal epithelial cells in the sediment were the important changes in the urine (table 111) . These features were observed after day 4 in the samples examined in trials 111 to VII. Slight to moderate concentration of glucose (0.25 mg/100 ml or more) was noted by days 3 t o 4 and was the first recorded alteration. By days 4 to 5 the urine of test dogs was slightly turbid and very pale yellow. The specific gravity ranged between 1.007 and 1.025 but was as low as 1.004 in one dog on day 6 (trial VII). With reagentstrip assays small to moderate amounts of protein were detected. Electrophoresis, however, showed large amounts of protein of low molecular weight in test dogs on day 1 in trial VIII. By day 2, the concentration of this protein was increased several fold. Blood, bile and urobilinogen were not detected in the test dogs. Slight ketonuria occurred in three dogs in the terminal stages of the toxicosis (days 11 to 13).
The turbid urine from test dogs was caused by suspended particulate matter. When the urine was centrifuged at 6,000 rpm for 3 min the supernatant was clear and there was a 2-to 4-mm white mass in the tip of the tube. This material was composed of granular casts, necrotic renal tubular epithelial cells, and amorphous debris. The granularity and physical characteristics of these casts were more readily appreciated when they were examined with dark-field illumination and by phase contrast microscopy ( fig. 6 ).
Blood Chemical Determinations and Hematology
Blood glucose in the test dogs in trials IV to VII decreased after day 10 ( fig. 3) ; in the control dogs it ranged from 120 to 200 mg/100 ml and in the test dogs in pretrial periods from 125 to 135 mg/100 ml. These high concentrations are not unusual in immature dogs. A decrease in this constituent was apparent as early as day 7 in some test dogs but values as low as 45, 54, and 60 mg/100 ml occurred in three dogs (trials IV to VI) that were in the terminal stages of the toxicosis. With the exception of two dogs that had terminal BUN'S of 50 and 110 mg/100 ml of serum (trials V and VII) BUN remained within normal limits and was comparable to control values ( fig. 3 ).
Concentrations of serum sodium, chloride and potassium decreased by day 10 in dogs given pure ochratoxin A in trial VII ( fig. 7) . The decrease of sodium and potassium was marked even in the presence of clinically apparent and progressive dehydration. Serum concentrations of sodium and chloride were never depressed to subnormal levels as were the terminal concentrations of potassium. In trials V to VII, BSP dye retention in test dogs on days 5, 8 and 12 was comparable to retention in pretrial determinations and in control dogs.
Clinically apparent dehydration in test dogs (trials 111 to VII) was responsible for progressive increases in PCV, hemoglobin, and total plasma proteins ( fig. 8 ). Consistent alterations in the total leukocyte count did not occur ( fig. 8 ) but in trial VI in one dog it fell from pretrial values of 29,000 and 25,000 cells/mm3 to 3,400 cells/mm3 on day 12. In trial VIII the total leukocyte count in another dog fell from pretrial values of 16,500 and 10,500 cells/ mm3 to 3,300 cells/mm3 on day 2. Differential leukocyte counts in test dogs had up to 50% band and juvenile forms. The lymphocyte to segmented-cell ratio was not altered.
No bacteria grew in cultures from the rice, urine, blood, lymph nodes, or livers.
Discussion
Clinical features of ochratoxicosis in Beagle dogs were anorexia, emesis, retching, tenesmus, elevated rectal temperature, bilateral purulent conjunctivitis, tonsillitis, polydipsia, polyuria, passage of clots of blood-stained mucus from the rectum, dehydration, prostration, and death. These signs are listed in their general order of occurrence during an 11-t o 14-day period in dogs given a daily oral dose of ochratoxin A of 0.2-0.3 mg/kg body weight. Dogs given ochratoxin A at daily doses of 3.0-8.0 mg/kg body weight were moribund by day 2. A no-effect level was apparently approached in trial IV; three dogs given daily oral doses of toxin of 0.1 mg/kg body weight for 21 days did not have detectable signs of toxicosis. When the dose was increased t o 0.2 mg/kg body weight on day 22, signs of mycotoxic disease appeared within 2 days, and by 4 to 6 days the dogs were moribund. These findings indicate that of those species studied the young Beagle dog is apparently the most sensitive t o ochratoxin A. The median lethal dose (LD,,) of orally administered ochratoxin A in ducklings was 25 pg per duckling in one report [63] and 150 pg in another [44] . The LD,, for ochratoxin A in chicks was estimated at 3.3-3.9 mg/kg body weight [16, 431 and in rats was about 20 mg/kg body weight [45] . The LD,, of intraperitoneally administered ochratoxin A in young trout was 4.7 mg/kg body weight [19] , and although several workers mention toxic effects in mice [53, 63, 691 , specific doses have not been reported.
The results of urinalysis and enzyme determinations indicate that in the dog ochratoxin A has a primary toxic effect on the renal tubular epithelium. Nephrotoxic effects of this mycotoxin have also been reported to occur in other species [15, 19, 38, 43, 451. Biochemical examination of the urine was of much benefit in detection of early renal disease. Concentrations of ICDH, LDH, GPT, GOT and LAP were increased in the urine as early as day 1, but a corresponding increase in serum concentrations of these enzymes did not occur.
The renal tubular origin of the urinary enzymes is indicated because the molecular weight of these proteins is far in excess of 70,000, which according t o BAYLISS et a/. [6] is the upper limit for enzymes that pass the glomerular membrane. Furthermore, the glomeruli appeared histologically normal, and contamination of the urine with leukocytes, erythrocytes, o r other extraneous materials, which can increase enzyme activities, did not occur. Renal tubular cells contain high concentrations of many enzymes in conjunction with their intense metabolic activity.
According to WROBLEWSKI and LADUE [68] the canine kidney has the highest activity of LDH. Dogs with renal injury induced by ischemia have had elevated LDH activity in urine [8] . Intravenous infusion of this enzyme in dogs and rabbits did not cause corresponding increases in L D H activity in the urine, but in rats toxic tubular damage induced by administration of sodium-tetrathionate increased L D H activity in the urine sixfold [46] . The concentration of LDH in urine has been suggested as a very sensitive method for the detection of renal tubular damage, and our findings support this.
In 1968, RAAB [46] reported increased activity of the enzyme ICDH in urine of rats with acute renal tubular damage of unspecified origin and stated that activity of this enzyme in urine had been measured only in that species. CHAFFEE et a/. [14] , in 1969, reported increased activities of ICDH in the plasma of dogs with aflatoxicosis.
The GOTactivity in urine of dogs with renal infarction was increased [51] , and renal origin again is indicated because intravenous administration of this enzyme in dogs did not increase urinary G O T activity [22] . Further support for the renal origin of the aminotransferases and other enzymes in urine was reported by DUBACH [21] . In trial VIlI, both GPT and G O T in the urine were increased by day 2. Pretrial concentrations of GPT in the urine were 9-10 mU/ml, and this value increased to 42 mU/ml on day 2. There was a much more pronounced elevation in urinary G O T which rose from pretrial values of 7-8 mU/ml t o 236 mU/ml on day 2. A similar change in the urine of rats, in which acute renal tubular damage was induced by the administration of sodium-tetrathionate, has been reported [46] .
Several workers have reported high concentrations of LAP in renal tubular cells [lo, 23, 29, 391 . Permeability factors on the brush borders of tubular epithelial cells and the turnover of these cells are responsible for the presence of this enzyme in urine [46] . High urinary LAP in rats with renal damage induced by mercury bichloride and sodium-tetrathionate has been reported [47] . In the present work urinary LAP was increased, and this was useful in assessing the renal damage.
Characteristic and consistent changes in the urine, such as low specific gravity, turbidity, glucosuria, and proteinuria accompanied the elevations of urinary enzymes. The urinary sediment was especially informative in assessing renal damage. Clumps of necrotic renal tubular epithelium as well as large numbers of single necrotic tubular epithelial cells were present in the urine by day 3, and by days 4 and 5 masses of granular casts occurred. Many necrotic cells were identified as tubular in that they were incorporated in or associated with casts [30] . Factors required for the initiation of cast formation in urine include increased concentrations of albumin [35, 361. In the normal dog insignificant amounts of this protein cross the glomerular barrier [18] . Increased urinary concentrations of a protein with electrophoretic mobility similar to albumin were demonstrated in trial VIII. Additional work on the origin and characterization of this protein is indicated since it may be albumin or 'tubular protein' as in the urine of human patients with renal tubular disease [ 1 1, 661.
The toxic effect of ochratoxin A on the kidney of the dog contrasts markedly to the slight effect on the liver. In this study serum concentrations of the liver-specific enzyme GGTP were not increased, and there was no consistent significant elevation of several other enzymes useful in evaluation of hepatic damage in dogs [27] . Results of the BSP dye excretion test did not suggest hepatic dysfunction.
Elevation of BUN in rats fed ochratoxin A was reported by MUNRO et al. [38] , but BUN was not often elevated in the dogs with ochratoxicosis. This difference in response may be caused in part by the failure of dogs to eat much food beyond the second day of the mycotoxicosis. The poor terminal condition of the dogs was attributed to renal failure. Concentrations of potassium in the serum of treated dogs progressively decreased to levels considered harmful for some tissues. Potassium depletion is known to impair renal function [28, 37, 42, 491 and to provoke a corresponding increase in urinary L D H and LAP [46] . Decreases in the serum sodium and chloride were less pronounced but they and the terminal hypoglycemia must be considered important in assessing the toxic response. Special Fellowship No. RR S1419. Published as paper number 4881 of the Agricultural Experiment Station, Purdue University, Lafayette, Tnd. The authors are indebted to Mr. N. NEIL HARRIS, Department of Medical Illustration, Purdue University, for preparation of the illustrative materials.
